Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice-Reference-Cited by-同舟云学术

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice

Published:2015-06 Issue: Volume:78 Page:172-195
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Yue M.,Hinkle K.M.,Davies P.,Trushina E.,Fiesel F.C.,Christenson T.A.,Schroeder A.S.,Zhang L.,Bowles E.,Behrouz B.,Lincoln S.J.,Beevers J.E.,Milnerwood A.J.,Kurti A.,McLean P.J.,Fryer J.D.,Springer W.,Dickson D.W.,Farrer M.J.,Melrose H.L.^ORCID

Funder

Mayo Clinic

NIH

Alzheimer's Association

Michael J. Fox Foundation

Publisher

Elsevier BV

Subject

Neurology

Reference115 articles.

1. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death;Angeles;Hum. Mutat.,2011

2. Dopamine release and metabolism in the rat striatum: an analysis by ‘in vivo’ brain microdialysis;Arbuthnott;Pharmacol. Ther.,1990

3. LRRK2 phosphorylates novel tau epitopes and promotes tauopathy;Bailey;Acta Neuropathol.,2013

4. Pharmacology of mesocortical dopamine neurons;Bannon;Pharmacol. Rev.,1983

5. Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs;Baptista;PLoS One,2013

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s LRRK2-G2019S risk gene mutation drives sex-specific behavioral and cellular adaptations to chronic variable stress;Frontiers in Behavioral Neuroscience;2024-09-12

2. LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting;Trends in Molecular Medicine;2024-08

3. Pathogenic LRRK2 causes age-dependent and region-specific deficits in ciliation, innervation and viability of cholinergic neurons;2024-07-18

4. Understanding role of pesticides in development of Parkinson's disease: Insights from Drosophila and rodent models;Ageing Research Reviews;2024-07

5. The LRRK2-G2019S mutation attenuates repair of brain injury partially by reducing the release of osteopontin-containing monocytic exosome-like vesicles;Neurobiology of Disease;2024-07